Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
GBL INV HSE (DFM: GLOBAL)
0.6150 AED  UNCHANGED
Daily Price  /  Updated: 6:00 AM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News
Stories about GBL INV HSE
 
< Previous 1 2 3 4 5 6 7 8 9
...
79 80 Next >
Australian Dollar Plummets as Central Bank Leaves the Door Open to More Rate Cuts
June 04, 2013
The Australian dollar dropped sharply against its U.S. counterpart Tuesday following strong gains Monday after the Reserve Bank of Australia (RBA) made a negative assessment of the economy. The bank... Read More
category Benzinga , Global , Economics , and 10 more.
from Latest Articles from Benzinga.com
Mid-Day Market Update: Stocks Pare Gains, G-III Apparel Surges On Q1 Results
June 04, 2013
Midway through trading Tuesday, the Dow traded up 0.01 percent to 15,256.10, while the NASDAQ rose 0.24 percent to 3,473.61. The S&P was also up, gaining 0.03 percent to 1,640.86. Top Headline Dollar... Read More
category ET , Earnings , Benzinga , and 17 more.
from Latest Articles from Benzinga.com
Mid-Morning Market Update: Markets Open Higher, Dollar General Profit Rises 3%
June 04, 2013
Following the market opening Tuesday, the Dow traded up 0.26 percent to 15,292.97, while the NASDAQ rose 0.31 percent to 3,476.05. The S&P was also up, gaining 0.29 percent to 1,645.14. Top Headline... Read More
category HNZ , ET , Earnings , and 18 more.
from Latest Articles from Benzinga.com
Trade Deficit Widens in April as Import Growth Outpaces Exports
June 04, 2013
The U.S. trade deficit widened in April from March as the growth in imports outpaced that of exports. Consumer goods imports saw a sharp increase in the month in a sign that the U.S. consumer may have... Read More
category QQQ , Benzinga , Global , and 15 more.
from Latest Articles from Benzinga.com
Retail Properties of America Recommends Rejection of $13.00/Share Mini-Tender Offer by Lapis
June 03, 2013
Retail Properties of America, Inc. (NYSE: RPAI ) has been notified of an unsolicited mini-tender offer by Lapis Investment Business Trust (“Lapis”) dated May 10, 2013, to purchase up to 100,000 shares... Read More
category Management , Benzinga , RPAI , and 6 more.
from Latest Articles from Benzinga.com
Heidrick &amp; Struggles Confirms it has been Approached Regarding a Possible Sale
June 03, 2013
Heidrick & Struggles International, Inc. (NASDAQ: HSII ), the premier professional services firm focused on serving the leadership needs of top organizations globally, today made the following... Read More
category Management , Benzinga , HSII , and 6 more.
from Latest Articles from Benzinga.com
AIG Announces Receipt of Notice from US Treasury
June 03, 2013
American International Group, Inc. (NYSE: AIG ) announced today that it has received notice from the U.S. Treasury that the Financial Stability Oversight Council has made a proposed determination that... Read More
category Management , Benzinga , AIG , and 6 more.
from Latest Articles from Benzinga.com
PetroLogistics Announces Temporary Outage at Production Facility Commencing June 8 for Repairs
June 03, 2013
PetroLogistics LP (NYSE: PDH ) (the "Partnership") announced today that it will temporarily bring down its propane dehydrogenation facility commencing on Saturday, June 8, 2013, for repairs pertaining... Read More
category Management , Benzinga , Global , and 5 more.
from Latest Articles from Benzinga.com
AUD to Benefit from Less-Dovish RBA -David Song, Currency Analyst at DailyFX, Comments on the Australian Dollar
June 03, 2013
"The AUDUSD pared the sharp decline from the previous month as the greenback struggled to hold its ground during the first trading day in June, and the pair may continue to track higher over the next... Read More
category Benzinga , Global , Forex , and 3 more.
from Latest Articles from Benzinga.com
Market Wrap for Monday, June 3: Stocks Rise to Start Week
June 03, 2013
Despite a very disappointing ISM reading for May which caused volatility in the currency markets, stocks did well to start the week on Monday. Blue chips led the way, with the Dow adding 1 percent. The... Read More
category Earnings , ZNGA , Benzinga , and 27 more.
from Latest Articles from Benzinga.com
Mid-Afternoon Market Update: Markets Recovering; Pandora Falls in Anticipation of Apple's Streaming Radio
June 03, 2013
Toward the end of trading Monday, the Dow traded up 0.57 percent to 15,201.55, while the NASDAQ fell 0.18 percent to 3,449.44. The S&P was also up, gaining 0.23 percent to 1,634.58. Top Headline... Read More
category Earnings , Benzinga , Movers , and 19 more.
from Latest Articles from Benzinga.com
Dividend Disappointments For Russia ETFs
June 03, 2013
It was not supposed to be like this. Russia, the "R" in the famous BRIC acronym and often one of the most heavily discounted emerging markets in terms of valuation, was supposed to become one of the... Read More
category Emerging Market ETFs , Benzinga , Global , and 14 more.
from Latest Articles from Benzinga.com
Japan's Nikkei Index Drops Overnight, Nears Bear Market Territory
June 03, 2013
Japan's benchmark Nikkei Index dropped a whopping 3.72 percent overnight, the fourth daily loss in eight trading days, as the index nears bear market territory after gaining over 60 percent in the past... Read More
category S , Benzinga , Global , and 11 more.
from Latest Articles from Benzinga.com
ISM Manufacturing Index Drops in May, Shows Contraction
June 03, 2013
The ISM Manufacturing Index was released Monday morning and it showed that the manufacturing sector contracted in May. The Index came in at 49.00, less than April's 50.7 and below the consensus... Read More
category Benzinga , ISM Manufacturing Index , Global , and 12 more.
from Latest Articles from Benzinga.com
Mid-Morning Market Update: Markets Rise, Cracker Barrel Posts Upbeat Earnings
June 03, 2013
Following the market opening Monday, the Dow traded up 0.69 percent to 15,220.16, while the NASDAQ rose 0.12 percent to 3,460.18. The S&P was also up, gaining 0.38 percent to 1,636.87. Top Headline... Read More
category Earnings , Benzinga , Movers , and 17 more.
from Latest Articles from Benzinga.com
A Look Ahead: This Week's ETFs to Watch
June 02, 2013
On the bright side, the month of May is now in the books and it is fair to say the "sell in May and go away crowd" did not inflict much damage. After all the, the S&P 500 rose 2.1 percent for the... Read More
category Specialty ETFs , Emerging Market ETFs , Benzinga , and 21 more.
from Latest Articles from Benzinga.com
UPDATE: ISS Supports SoftBank/Sprint Merger
June 02, 2013
Sprint (NYSE: S ) and SoftBank (TSE: 9984) announced today that leading proxy advisory firm Institutional Stockholder Services (“ISS”) has recommended that Sprint stockholders vote in favor of the... Read More
category S , Management , Benzinga , and 6 more.
from Latest Articles from Benzinga.com
Bristol-Myers Squibb Reports Phase 1 Results from Advanced Melanoma Trial
June 02, 2013
Bristol-Myers Squibb Company (NYSE: BMY ) today announced results from Study 004, a dose-ranging Phase 1 trial (n=86) evaluating the safety and anti-tumor activity of its investigational PD-1 Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Infinity Presents Updated Phase 1 Data Showing Encouraging Clinical Activity of IPI-145 in Chronic Lymphocytic Leukemia at ASCO
June 02, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI ) today announced updated Phase 1 data from an ongoing study of IPI-145, its potent, oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma... Read More
category Contracts , Management , INFI , and 4 more.
from Latest Articles from Benzinga.com
ARIAD Presents Long-Term Durability-of-Response Data from Phase 1 Trial of Iclusig
June 02, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA ) today announced long-term durability-of-response data from its Phase 1 trial of Iclusig® (ponatinib) in heavily pretreated patients with resistant or... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
ARIAD Announces Updated Clinical Results on AP26113 in Patients with Non-Small Cell Lung Cancer
June 02, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA ) today announced updated clinical results on its investigational tyrosine kinase inhibitor (TKI), AP26113, in patients with advanced non-small cell lung... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Exelixis Presents Positive COMETRIQ Clinical Trial Data in Patients with Progressive, Metastatic Medullary Thyroid Cancer
June 02, 2013
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (NASDAQ: EXEL ) today announced the presentation of additional data from clinical trials of COMETRIQ™ (cabozantinib) in patients with... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Seattle Genetics Highlights ADCETRIS Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate Collaborator Data at ASCO
June 02, 2013
Seattle Genetics, Inc. (NASDAQ: SGEN ) today highlighted ongoing clinical development programs for ADCETRIS (brentuximab vedotin) in frontline Hodgkin lymphoma (HL) and mature T-cell lymphoma (MTCL)... Read More
category SGEN , Contracts , Management , and 4 more.
from Latest Articles from Benzinga.com
Novartis Afinitor Pivotal Phase 3 Trial Shows Significant Delay in Tumor Growth In HER2 Positive Advanced Breast Cancer
June 02, 2013
Novartis International AG (NYSE: NVS ) / Novartis pivotal Phase III trial shows Afinitor® significantly delays tumor growth in HER2 positive advanced breast cancer . Processed and transmitted by... Read More
category NVS , Contracts , Management , and 4 more.
from Latest Articles from Benzinga.com
Genentech Announces Final Results from Phase 3 AVAglio Study in People with Glioblastoma
June 01, 2013
Genentech, a member of the Roche Group (OTC: RHHBY ), today announced final results from the Phase III AVAglio study in people with newly diagnosed glioblastoma, the most common and aggressive form Read More
category Contracts , RHHBY , Management , and 4 more.
from Latest Articles from Benzinga.com
ArQule Announces Phase 2 Study Results for Tivantinib in Combination with Cetuximab and Irinotecan for Colorectal Cancer at ASCO
June 01, 2013
ArQule, Inc. (NASDAQ: ARQL ) today announced final data from a randomized, placebo-controlled, double-blind, Phase 2 clinical trial with tivantinib in combination with cetuximab and irinotecan in... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Assured Guaranty Buys Back 5M Shares from WL Ross @$21.94/Share
June 01, 2013
Assured Guaranty Ltd. (the Company or, together with its subsidiaries, Assured Guaranty) has agreed to purchase, as part of its previously announced share repurchase program, 5 million of its common... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
Takeda Presents Phase 1/2 Clinical Trial Data from Study of ADCETRIS in Pediatric Patients
June 01, 2013
Takeda Pharmaceutical Company Limited (OTC: TKPYY ) today announced interim data from a Phase 1/2, open-label, multicenter study with ADCETRIS® (brentuximab vedotin) in pediatric patients diagnosed... Read More
category TKPYY , Contracts , Management , and 4 more.
from Latest Articles from Benzinga.com
ZIOPHARM Presents Updated Results from Phase 1 Ad-RTS-IL-12 Study in Advanced Melanoma at ASCO
June 01, 2013
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP ) today announced updated results from the Phase 1 study in advanced melanoma using Ad-RTS-IL-12, a novel DNA-based therapeutic candidate. Findings were presented... Read More
category Contracts , ZIOP , Management , and 4 more.
from Latest Articles from Benzinga.com
Incyte Presents Phase I Trial Results of INCB024360 at ASCO
June 01, 2013
Incyte Corporation (NASDAQ: INCY ) presented final results today from the Phase I clinical trial for its oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB024360, at the American Society of Clinical... Read More
category Contracts , Management , Benzinga , and 4 more.
from Latest Articles from Benzinga.com
< Previous 1 2 3 4 5 6 7 8 9
...
79 80 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here